Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Clinical and Experimental Dermatology|October 24, 2000
Mechanisms of metastasisP Kurschat, C Mauch
Der Internist|February 2, 2013
[Personalized therapy concepts for malignant melanoma]M Schlaak, N Kreuzberg, C Mauch, et al.
Dermatology Online Journal|September 10, 2005
Keratoacanthoma centrifugum marginatum accompanied by extensive granulomatous foreign body reactionP Kurschat, S Hess, N Hunzelmann, et al.
Case Reports in Dermatology|May 2, 2012
Successful Treatment of a Panniculitis-Like Primary Cutaneous T-Cell Lymphoma of the α/β Type with BexaroteneX Zhang, M Schlaak, M Fabri, et al.
The British Journal of Dermatology|February 1, 2007
Early increase in serum levels of the angiogenesis-inhibitor endostatin and of basic fibroblast growth factor in melanoma patients during disease progressionP Kurschat, S Eming, D Nashan, et al.
Critical Reviews in Oncology/Hematology|July 24, 2012
Allogeneic stem cell transplantation for advanced primary cutaneous T-cell lymphoma: a systematic reviewM Schlaak, S Theurich, J Pickenhain, et al.
The Journal of Biological Chemistry|July 20, 1999
Tissue inhibitor of matrix metalloproteinase-2 regulates matrix metalloproteinase-2 activation by modulation of membrane-type 1 matrix metalloproteinase activity in high and low invasive melanoma cell linesP Kurschat, P Zigrino, R Nischt, et al.
Transplant Immunology|July 13, 2011
Donor lymphocyte infusions combined with systemic PUVA/bexarotene as an effective bimodal immunologic approach in a patient with relapsed cutaneous T cell lymphoma after allogeneic stem cell transplantationM Schlaak, P Kurschat, A Shimabukuro-Vornhagen, et al.
European Journal of Biochemistry|December 1, 1995
Expression of a biologically active murine tissue inhibitor of metalloproteinases-1 (TIMP-1) in baculovirus-infected insect cells. Purification and tissue distribution in the ratP Kurschat, L Graeve, A Erren, et al.
The British Journal of Dermatology|March 27, 2013
Assessment of clinical parameters associated with mutational status in metastatic malignant melanoma: a single-centre investigation of 141 patientsM Schlaak, A Bajah, T Podewski, et al.
Pageof 2